Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
JAK Inhibitors Improve Vitiligo, Trials ShowSeparate clinical trials of ruxolitinib and ritlecitinib showed both therapies resulted in significant repigmentation in patients
with vitiligo.
Medscape Medical News, Apr 08, 2022
For Pemphigus, Rituximab Is First Line, Expert SaysLower healthcare costs and efficacy put rituximab ahead of traditional treatments, such as corticosteroids, doxycycline, and
immunomodulators, for the autoimmune blistering disease, an expert said.
